Home > Insider Trading > Filing (0001209191-22-045116)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1812025	Justin Burgess	C/O Dynavax Technologies 2100 Powell Street, Suite 720 Emeryville CA 94608	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-08-08	10,472	$5.42	14,326	No	4	M	Direct
Common Stock	Acquisiton	2022-08-08	8,200	$9.41	22,526	No	4	M	Direct
Common Stock	Disposition	2022-08-08	18,672	$16.72	3,854	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-08-08	10,472	$0.00	10,472	$5.42
Common Stock	Stock Option (Right to Buy)	Disposition	2022-08-08	8,200	$0.00	8,200	$9.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,528		2027-02-11	No	4	M	Direct
8,400		2028-02-02	No	4	M	Direct

Footnotes

All shares were sold at $16.72.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 12, 2020, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
Not applicable.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.